Insulet Reports Fourth Quarter Revenue of $130.5 Million, Up 26%, and Gross Margin Up 210 Basis Points, Exceeding Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St futures slip as oil surge puts markets on edge
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Insulet Corporation (PODD) PT Raised to $90 at Cowen; Beat and Raise
February 22, 2018 6:55 AM ESTCowen raised its price target on Insulet Corporation (NASDAQ: PODD) to $90.00 (from $80.00) while maintaining a Outperform rating.
Analyst Doug Schenkel commented, "PODD posted another strong beat and initiated 2018 guidance well ahead of expectations at the top and bottom lines, despite lighter than expected... More
Insulet (PODD) Misses Q4 EPS by 4c, Revs Beat
February 21, 2018 4:01 PM ESTInsulet (NASDAQ: PODD) reported Q4 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $130.5 million versus the consensus estimate of $125.15 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
... More